의약품 제조 설비 시장 규모, 점유율, 성장 및 세계 산업 분석 : 유형별, 용도별, 지역별 인사이트와 예측(2024-2032년)

Growth Factors of pharmaceutical manufacturing equipment Market

The global pharmaceutical manufacturing equipment market is undergoing a strong expansion phase driven by the increasing demand for medicines, rapid advancements in production technologies, and stringent regulatory frameworks governing drug development and manufacturing. According to the 2024 industry assessment, the global pharmaceutical manufacturing equipment market size reached USD 22.36 billion in 2024. This value is projected to rise to USD 23.67 billion in 2025, ultimately reaching USD 38.82 billion by 2032, reflecting steady industry progress supported by innovation, automation, and rising pharmaceutical needs worldwide. The market advances at a CAGR of 7.33% between 2025 and 2032, highlighting long-term growth opportunities across both developed and emerging economies.

Market Overview and Growth Drivers

The market's expansion is propelled by rising production of generic medicines, biologics, vaccines, and advanced therapeutics. Increasing healthcare needs, aging populations, and chronic disease prevalence have pushed pharmaceutical companies to scale up production, requiring high-performance equipment with improved efficiency, precision, and compliance capabilities. Additionally, the shift toward precision medicine and biopharmaceuticals has accelerated investment in technologically advanced solutions such as continuous manufacturing, automated filling systems, high-capacity granulators, and contamination-control equipment.

COVID-19 significantly transformed the sector by elevating the global demand for vaccine and therapeutic manufacturing capacity. As a result, pharmaceutical companies and equipment manufacturers increased investments in automation, digital monitoring, and flexible high-speed machines capable of supporting large-scale emergency production. These factors continue to influence the market's evolution even post-pandemic.

Impact of IoT and Automation

The integration of IoT, predictive analytics, and remote monitoring has reshaped the industry's operational efficiencies. IoT-enabled equipment enhances quality control, regulatory adherence, and production speed through real-time data collection and automated decision-making. Automation also reduces labor requirements and minimizes human error, enabling pharmaceutical plants to maintain consistent output.

In 2024, notable advancements included the Korber-AspenTech partnership, which integrated PAS-X MES with advanced data solutions to optimize shopfloor operations. This strengthened pharmaceutical companies' digital transformation efforts and improved overall manufacturing intelligence.

Market Trends Transforming the Industry

The adoption of Single Use Technologies (SUT) is rising rapidly due to their ability to minimize contamination risks, reduce cleaning requirements, and support flexible biologics production. Continuous manufacturing is also becoming mainstream, helping companies reduce production times and increase throughput. Advanced anti-counterfeiting technologies such as track-and-trace solutions and automated sterilization systems are gaining prominence to ensure product integrity.

In June 2024, GEA Group introduced the first single-use disc centrifuge for perfusion, expanding continuous manufacturing capabilities across biopharma applications-reflecting ongoing investment in next-generation pharmaceutical equipment.

Regional Outlook

Asia Pacific dominated the global market in 2024 with a 41.64% share, reaching USD 9.31 billion in value. The region benefits from strong manufacturing capabilities, cost-effective production environments, technological advancements in China, and increasing pharmaceutical investments across India, Japan, and South Korea. In 2025, China is expected to reach USD 4.06 billion, India USD 2.25 billion, and Japan USD 1.35 billion, underscoring Asia's leadership in pharma manufacturing.

North America remains a major contributor, expected to achieve USD 7.35 billion in 2025, supported by advanced R&D infrastructure, strong regulatory standards, and early adoption of innovative technologies. Europe is projected to reach USD 3.94 billion in 2025, driven by high-quality manufacturing standards and Industry 4.0 integration.

Competitive Landscape

The pharmaceutical manufacturing equipment market consists of global leaders including GEA Group AG, Syntegon Technology GmbH, Sartorius AG, ACG, IMA, Glatt GmbH, Romaco, Fette Compacting, Paul Mueller, Shimadzu Corporation, Thermo Fisher Scientific, and Merck KGaA. Companies continually invest in R&D, collaborate with contract manufacturers, and innovate equipment to enhance speed, safety, and automation. In 2024 alone, new sterilizers, continuous tableting systems, and advanced aseptic spray-drying solutions were introduced, expanding technological capabilities.

Segmentation By Equipment

• Mixing & Blending
• Milling
• Dryer & Granulators
• Extrusion
• Filling & Compression
• Inspection & Sterilization
• Packaging, etc.

By Manufacturing Type

• Continuous
• Batch

By End User

• Large Scale Pharma
• CDMO
• CMO
• CRO

By Region

• North America (By Equipment, By Manufacturing Type, By End User, and By Country)
  • U.S. (By End User)
  • Canada (By End User)
  • Mexico (By End User)
• Europe (By Equipment, By End User, and By Country)
  • U.K. (By End User)
  • Germany (By End User)
  • France (By End User)
  • Italy (By End User)
  • Switzerland (By End User)
  • Spain (By End User)
  • Rest of Europe
• Asia Pacific (By Equipment, By End User, and By Country)
  • China (By End User)
  • India (By End User)
  • Japan (By End User)
  • South Korea (By End User)
  • ASEAN (By End User)
  • Rest of Asia Pacific
• Middle East & Africa (By Equipment, By End User, and By Country)
  • South Africa (By End User)
  • GCC (By End User)
  • Rest of Middle East & Africa
• South America (By Equipment, By End User, and By Country)
  • Brazil (By End User)
  • Argentina (By End User)
  • Rest of South America

Key Market Players Profiled in the Report GEA Group AG (Germany), Syntegon Technology GmbH (Germany), Sartorius AG (Germany), ACG (India), IMA Group (Italy), Glatt GmbH (Germany), Romaco Group (Germany), Fette Compacting (Germany), Paul Mueller (U.S.), SED Pharma (China), etc.

Table of Content

1. Introduction

• 1.1. Definition, By Segment
• 1.2. Research Methodology/Approach
• 1.3. Data Sources

2. Executive Summary

3. Market Dynamics

• 3.1. Macro and Micro Economic Indicators
• 3.2. Drivers, Restraints, Opportunities and Trends
• 3.3. Impact of IoT and Automation

4. Competition Landscape

• 4.1. Business Strategies Adopted by Key Players
• 4.2. Consolidated SWOT Analysis of Key Players
• 4.3. Global Pharmaceutical Manufacturing Equipment Key Players [Top 3-5] Market Share/Ranking, 2024

5. Global Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Segments, 2019-2032

• 5.1. Key Findings
• 5.2. By Equipment (USD)
  • 5.2.1. Mixing & Blending
  • 5.2.2. Milling
  • 5.2.3. Dryer & Granulators
  • 5.2.4. Extrusion
  • 5.2.5. Filling & Compression
  • 5.2.6. Inspection & Sterilization
  • 5.2.7. Packaging, etc.
• 5.3. By Manufacturing Type (USD)
  • 5.3.1. Continuous
  • 5.3.2. Batch
• 5.4. By End User (USD)
  • 5.4.1. Large Scale Pharmas
  • 5.4.2. CDMO
  • 5.4.3. CMO
  • 5.4.4. CRO
• 5.5. By Region (USD)
  • 5.5.1. North America
  • 5.5.2. South America
  • 5.5.3. Europe
  • 5.5.4. Asia Pacific
  • 5.5.5. Middle East & Africa

6. North America Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Segments, 2019-2032

• 6.1. Key Findings
• 6.2. By Equipment (USD)
  • 6.2.1. Mixing & Blending
  • 6.2.2. Milling
  • 6.2.3. Dryer & Granulators
  • 6.2.4. Extrusion
  • 6.2.5. Filling & Compression
  • 6.2.6. Inspection & Sterilization
  • 6.2.7. Packaging, etc.
• 6.3. By Manufacturing Type (USD)
  • 6.3.1. Continuous
  • 6.3.2. Batch
• 6.4. By End User (USD)
  • 6.4.1. Large Scale Pharmas
  • 6.4.2. CDMO
  • 6.4.3. CMO
  • 6.4.4. CRO
• 6.5. By Country (USD)
  • 6.5.1. United States
    • 6.5.1.1. By End User
  • 6.5.2. Canada
    • 6.5.2.1. By End User
  • 6.5.3. Mexico
    • 6.5.3.1. By End User

7. South America Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Segments, 2019-2032

• 7.1. Key Findings
• 7.2. By Equipment (USD)
  • 7.2.1. Mixing & Blending
  • 7.2.2. Milling
  • 7.2.3. Dryer & Granulators
  • 7.2.4. Extrusion
  • 7.2.5. Filling & Compression
  • 7.2.6. Inspection & Sterilization
  • 7.2.7. Packaging, etc.
• 7.3. By Manufacturing Type (USD)
  • 7.3.1. Continuous
  • 7.3.2. Batch
• 7.4. By End User (USD)
  • 7.4.1. Large Scale Pharmas
  • 7.4.2. CDMO
  • 7.4.3. CMO
  • 7.4.4. CRO
• 7.5. By Country (USD)
  • 7.5.1. Brazil
    • 7.5.1.1. By End User
  • 7.5.2. Argentina
    • 7.5.2.1. By End User
  • 7.5.3. Rest of South America

8. Europe Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Segments, 2019-2032

• 8.1. Key Findings
• 8.2. By Equipment (USD)
  • 8.2.1. Mixing & Blending
  • 8.2.2. Milling
  • 8.2.3. Dryer & Granulators
  • 8.2.4. Extrusion
  • 8.2.5. Filling & Compression
  • 8.2.6. Inspection & Sterilization
  • 8.2.7. Packaging, etc.
• 8.3. By Manufacturing Type (USD)
  • 8.3.1. Continuous
  • 8.3.2. Batch
• 8.4. By End User (USD)
  • 8.4.1. Large Scale Pharmas
  • 8.4.2. CDMO
  • 8.4.3. CMO
  • 8.4.4. CRO
• 8.5. By Country (USD)
  • 8.5.1. United Kingdom
    • 8.5.1.1. By End User
  • 8.5.2. Germany
    • 8.5.2.1. By End User
  • 8.5.3. France
    • 8.5.3.1. By End User
  • 8.5.4. Italy
    • 8.5.4.1. By End User
  • 8.5.5. Switzerland
    • 8.5.5.1. By End User
  • 8.5.6. Spain
    • 8.5.6.1. By End User
  • 8.5.7. Rest of Europe

9. Asia Pacific Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Segments, 2019-2032

• 9.1. Key Findings
• 9.2. By Equipment (USD)
  • 9.2.1. Mixing & Blending
  • 9.2.2. Milling
  • 9.2.3. Dryer & Granulators
  • 9.2.4. Extrusion
  • 9.2.5. Filling & Compression
  • 9.2.6. Inspection & Sterilization
  • 9.2.7. Packaging, etc.
• 9.3. By Manufacturing Type (USD)
  • 9.3.1. Continuous
  • 9.3.2. Batch
• 9.4. By End User (USD)
  • 9.4.1. Large Scale Pharmas
  • 9.4.2. CDMO
  • 9.4.3. CMO
  • 9.4.4. CRO
• 9.5. By Country (USD)
  • 9.5.1. China
    • 9.5.1.1. By End User
  • 9.5.2. India
    • 9.5.2.1. By End User
  • 9.5.3. Japan
    • 9.5.3.1. By End User
  • 9.5.4. South Korea
    • 9.5.4.1. By End User
  • 9.5.5. ASEAN
    • 9.5.5.1. By End User
  • 9.5.6. Rest of Asia Pacific

10. Middle East & Africa Pharmaceutical Manufacturing Equipment Market Size Estimates and Forecasts, By Segments, 2019-2032

• 10.1. Key Findings
• 10.2. By Equipment (USD)
  • 10.2.1. Mixing & Blending
  • 10.2.2. Milling
  • 10.2.3. Dryer & Granulators
  • 10.2.4. Extrusion
  • 10.2.5. Filling & Compression
  • 10.2.6. Inspection & Sterilization
  • 10.2.7. Packaging, etc.
• 10.3. By Manufacturing Type (USD)
  • 10.3.1. Continuous
  • 10.3.2. Batch
• 10.4. By End User (USD)
  • 10.4.1. Large Scale Pharmas
  • 10.4.2. CDMO
  • 10.4.3. CMO
  • 10.4.4. CRO
• 10.5. By Country (USD)
  • 10.5.1. South Africa
    • 10.5.1.1. By End User
  • 10.5.2. GCC
    • 10.5.2.1. By End User
  • 10.5.3. Rest of MEA

11. Company Profiles for Top 10 Players (Based on data availability in public domain and/or on paid databases)

• 11.1. GEA Group
  • 11.1.1. Overview
    • 11.1.1.1. Key Management
    • 11.1.1.2. Headquarters
    • 11.1.1.3. Offerings/Business Segments
  • 11.1.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.1.2.1. Employee Size
    • 11.1.2.2. Past and Current Revenue
    • 11.1.2.3. Geographical Share
    • 11.1.2.4. Business Segment Share
    • 11.1.2.5. Recent Developments
• 11.2. Romaco Group
  • 11.2.1. Overview
    • 11.2.1.1. Key Management
    • 11.2.1.2. Headquarters
    • 11.2.1.3. Offerings/Business Segments
  • 11.2.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.2.2.1. Employee Size
    • 11.2.2.2. Past and Current Revenue
    • 11.2.2.3. Geographical Share
    • 11.2.2.4. Business Segment Share
    • 11.2.2.5. Recent Developments
• 11.3. IMA Group
  • 11.3.1. Overview
    • 11.3.1.1. Key Management
    • 11.3.1.2. Headquarters
    • 11.3.1.3. Offerings/Business Segments
  • 11.3.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.3.2.1. Employee Size
    • 11.3.2.2. Past and Current Revenue
    • 11.3.2.3. Geographical Share
    • 11.3.2.4. Business Segment Share
    • 11.3.2.5. Recent Developments
• 11.4. Syntegon Technology
  • 11.4.1. Overview
    • 11.4.1.1. Key Management
    • 11.4.1.2. Headquarters
    • 11.4.1.3. Offerings/Business Segments
  • 11.4.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.4.2.1. Employee Size
    • 11.4.2.2. Past and Current Revenue
    • 11.4.2.3. Geographical Share
    • 11.4.2.4. Business Segment Share
    • 11.4.2.5. Recent Developments
• 11.5. Sartorius AG
  • 11.5.1. Overview
    • 11.5.1.1. Key Management
    • 11.5.1.2. Headquarters
    • 11.5.1.3. Offerings/Business Segments
  • 11.5.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.5.2.1. Employee Size
    • 11.5.2.2. Past and Current Revenue
    • 11.5.2.3. Geographical Share
    • 11.5.2.4. Business Segment Share
    • 11.5.2.5. Recent Developments
• 11.6. ACG Group
  • 11.6.1. Overview
    • 11.6.1.1. Key Management
    • 11.6.1.2. Headquarters
    • 11.6.1.3. Offerings/Business Segments
  • 11.6.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.6.2.1. Employee Size
    • 11.6.2.2. Past and Current Revenue
    • 11.6.2.3. Geographical Share
    • 11.6.2.4. Business Segment Share
    • 11.6.2.5. Recent Developments
• 11.7. Fette Compacting GmbH
  • 11.7.1. Overview
    • 11.7.1.1. Key Management
    • 11.7.1.2. Headquarters
    • 11.7.1.3. Offerings/Business Segments
  • 11.7.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.7.2.1. Employee Size
    • 11.7.2.2. Past and Current Revenue
    • 11.7.2.3. Geographical Share
    • 11.7.2.4. Business Segment Share
    • 11.7.2.5. Recent Developments
• 11.8. Glatt
  • 11.8.1. Overview
    • 11.8.1.1. Key Management
    • 11.8.1.2. Headquarters
    • 11.8.1.3. Offerings/Business Segments
  • 11.8.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.8.2.1. Employee Size
    • 11.8.2.2. Past and Current Revenue
    • 11.8.2.3. Geographical Share
    • 11.8.2.4. Business Segment Share
    • 11.8.2.5. Recent Developments
• 11.9. Paul Mueller Company
  • 11.9.1. Overview
    • 11.9.1.1. Key Management
    • 11.9.1.2. Headquarters
    • 11.9.1.3. Offerings/Business Segments
  • 11.9.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.9.2.1. Employee Size
    • 11.9.2.2. Past and Current Revenue
    • 11.9.2.3. Geographical Share
    • 11.9.2.4. Business Segment Share
    • 11.9.2.5. Recent Developments
• 11.10. SED Pharma
  • 11.10.1. Overview
    • 11.10.1.1. Key Management
    • 11.10.1.2. Headquarters
    • 11.10.1.3. Offerings/Business Segments
  • 11.10.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.10.2.1. Employee Size
    • 11.10.2.2. Past and Current Revenue
    • 11.10.2.3. Geographical Share
    • 11.10.2.4. Business Segment Share
    • 11.10.2.5. Recent Developments

12. Key Takeaways